Sponsored Research Grants
.................................................................................................................................................................................................
Title: Development of Nitric oxide donating Acridones as inhibitors of MDR in cancer cells.
Funding Agency: VI–D&P/623/2018-19/TDT DPRP/DST.
Amount (INR): 1,41,00,000.
Duration: 3 Years.
PI/Co-PI: Dr.V.V.S.Rajendra Prasad & Dr.A.Ramesh.
Status: Sanctioned.
...........................................................................................................................................................................................................
Title: Development of an affordable test kit for early detection of colon cancer and GIT disorders
Funding Agency: IDEATS/003112, MSME
Amount (INR): 14,58,000
Duration: 3 Years.
PI/Co-PI: Dr.V.V.S.Rajendra Prasad
Status: Ongoing.
...........................................................................................................................................................................................................
Title: Nitric oxide releasing Quinilones derivatives as inhibitors of doxorubicine resistance in cancer
Funding Agency: 8-173/FDC/RPS/2O21-22, AICTE
Amount (INR): 10,58,680
Duration: 3 Years.
PI/Co-PI: Dr.V.V.S.Rajendra Prasad & Dr.B.Jahavi
Status: Ongoing.
.............................................................................................................................................................................................................
Title: Spirnula Biomass Cultivation, isolations of chemical constitutes and commercial exploration.
Funding Agency: SEED/SCSP/2019/80
Amount (INR): 77,86,202.
Duration: 3 Years.
PI/Co-PI: Dr.Vanitha & Dr.D.Santosha
Status: Ongoing.
...........................................................................................................................................................................................................
Title: Development and characterization of polymer based letrozole loaded na no particulate formulation to induce programmed cellular death in breast cancer,in vitro and invivo studies.
Funding Agency: ICMR, 3-2-217/2019
Amount (INR): 15,67,000.
Duration: 3 Years.
PI/Co-PI: Dr.V.V.S.Rajendra Prasad & Mrs M.Sandhya.
Status: Ongoing.
...........................................................................................................................................................................................................
Title: In-silico optimization and synthesis of novel andragrapholade analogues as PI3K Inhibitors.
Funding Agency: ICMR, 3-2-2-56/2019
Amount (INR): 15,37,000.
Duration: 3 Years.
PI/Co-PI: Y.Viswanadham.
Status: Completed.
...........................................................................................................................................................................................................
Title: Structural insights to inhibit Epidermal Growth Factor Receptor (EGFR) dimerization & activation: Panitumumab induced Conformational study.
Funding Agency: DBT, [6242-P55/RGCB/PBD/DBT,APDK/2015]
Amount (INR): 32,75,480.
Duration: 3 Years.
PI/Co-PI: Dr.V.V.S.Rajendra Prasad
Status: Completed.
...........................................................................................................................................................................................................
Title: Binding kinetics & Interaction analysis of Pertuzumab in complex with isolated extracellular domain II (sHER2 dII) & domain IV (sHER2 dIV) of (sHER2): Structural Implications in the inhibition of HER2/HER3 mediated dimerization and activation.
Funding Agency: SERB, [YSS/2014/002005].
Amount (INR): 27,90,000
Duration: 3 Years.
PI/Co-PI: Dr.Dokala.A
Status: Completed.
...........................................................................................................................................................................................................
Title: Projects under Institute - Industry Innovation Cell (IIIC).
Funding Agency: MSME (FMC)
Amount (INR): 3,29,000
Duration: 3 Years.
PI/Co-PI: Dr.Ramesh & Mr.P.Prabakar
Status: Completed.
...........................................................................................................................................................................................................
Title: Neuroprotective activity of polyherbal formulation aganist transient global ischemia induced brain damage in normal and alloxan induced diabetic rats.
Funding Agency: DST, SR/WOS-A/LS-491/2012
Amount (INR): 21,00,000
Duration: 3 Years.
PI/Co-PI: Dr.D.Santosha
Status: Completed.
...........................................................................................................................................................................................................
Title: Formulation evaluation and optimization of floating drug delidery system of antihypertensive drugs.
Funding Agency: DST, SR/WOS-A/CS-77/2012
Amount (INR): 22,50,000
Duration: 3 Years.
PI/Co-PI: Mrs S.Sandhyarani
Status: Completed.
...........................................................................................................................................................................................................
Title Optimization and evaluation of prazosin floating microspheres using response surface methodology
Funding Agency: DST, SR/WOS-A/LS-496/2012
Amount (INR): 21,20,000
Duration: 3 Years.
PI/Co-PI: Dr.K.Vanitha
Status: Completed.
...........................................................................................................................................................................................................
Title Role of individual isoforms of Phosphoinositide 3-kinase (PI3K) inhibitors and non-selective inhibitors in in vivo models of Alzheimer's disease (AD).
Funding Agency: DST, SR/CSI/107/2012(G)
Amount (INR): 48,20,000
Duration: 3 Years.
PI/Co-PI: Dr.A.Ramesh
Status: Completed.
...........................................................................................................................................................................................................
Title Travel Grant sanctioned to present research paper in FEBS EMBO-14 30 Aug - 4 Sep 2014 in PARIS, FRANCE.
Funding Agency: DST, [SERB/F/7397/2014-15]
Amount (INR): 1,35,000
Duration: 1 Years.
PI/Co-PI: Mr.G.Deepak Reddy
Status: Completed.
...........................................................................................................................................................................................................
Title: Travel Grant sanctioned to present research paper in the GTC conference “Protein Kinases and Drug Design” BOSTON, USA on 08-10th Nov, 2012.
Funding Agency: DST, [SR/ITS/3737/2012-13]
Amount (INR): 1,37,580.
Duration: 3 Years.
PI/Co-PI: Dr.V.V.S.Rajendra Prasad
Status: Completed.
...........................................................................................................................................................................................................
Title: Mechanistic Studies: Acridones as reverters of multidrug resistance (MDR) in cancer
Funding Agency: AICTE, [1-51/RIFD/CA/11/2011-12]
Amount (INR): 9,00,000
Duration: 3 Years.
PI/Co-PI: Dr.V.V.S.Rajendra Prasad
Status: Completed.
...........................................................................................................................................................................................................
Title: Design and Synthesis of nitric oxide donating phenoxazine derivatives as reverters of multidrug resistance (MDR) in cancer.
Funding Agency: SERB, [SR/FT/LS-75/2009]
Amount (INR): 18,02,000
Duration: 3 Years.
PI/Co-PI: Dr.V.V.S.Rajendra Prasad
Status: Completed.
...........................................................................................................................................................................................................
